Raymond Goodrich Terumo BCT Scientific Affairs Biography Publications Institution JoVE Articles Raymond Goodrich has not added a biography. If you are Raymond Goodrich and would like to personalize this page please email our Author Liaison for assistance. Publications Inactivation of Viruses in Platelet and Plasma Products Using a Riboflavin-and-UV-based Photochemical Treatment Transfusion. Jul, 2015 | Pubmed ID: 25731607 Large Animal Evaluation of Riboflavin and Ultraviolet Light-treated Whole Blood Transfusion in a Diffuse, Nonsurgical Bleeding Porcine Model Transfusion. Mar, 2015 | Pubmed ID: 25582335 Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage Shock (Augusta, Ga.). Aug, 2015 | Pubmed ID: 25423125 Reduction of Leishmania Donovani Infectivity in Whole Blood Using Riboflavin and Ultraviolet Light Transfusion. Feb, 2015 | Pubmed ID: 25156473 The Effect of Riboflavin and Ultraviolet Light on the Infectivity of Arboviruses Transfusion. Nov, 2014 | Pubmed ID: 25370822 Whole Blood Treated with Riboflavin and Ultraviolet Light: Quality Assessment of All Blood Components Produced by the Buffy Coat Method Transfusion. Oct, 2014 | Pubmed ID: 25355434 Chemical and Biological Mechanisms of Pathogen Reduction Technologies Photochemistry and Photobiology. Sep-Oct, 2014 | Pubmed ID: 25041351 Plasma Constituent Integrity in Pre-storage Vs. Post-storage Riboflavin and UV-light Treatment--a Comparative Study Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Dec, 2013 | Pubmed ID: 23820430 Riboflavin and Ultraviolet Light Treatment of Platelets Triggers P38MAPK Signaling: Inhibition Significantly Improves in Vitro Platelet Quality After Pathogen Reduction Treatment Transfusion. Dec, 2013 | Pubmed ID: 23521225 Immune Modulation and Lack of Alloimmunization Following Transfusion with Pathogen-reduced Platelets in Mice Transfusion. Mar, 2013 | Pubmed ID: 23451715 Inactivation of Plasmodium Spp. in Plasma and Platelet Concentrates Using Riboflavin and Ultraviolet Light Transfusion. Oct, 2013 | Pubmed ID: 23320495 Primary Hemostatic Capacity of Whole Blood: a Comprehensive Analysis of Pathogen Reduction and Refrigeration Effects over Time Transfusion. Jan, 2013 | Pubmed ID: 23301966 Development of a Riboflavin and Ultraviolet Light-based Device to Treat Whole Blood Transfusion. Jan, 2013 | Pubmed ID: 23301965 A Pilot Study to Assess the Hemostatic Function of Pathogen-reduced Platelets in Patients with Thrombocytopenia Transfusion. Sep, 2013 | Pubmed ID: 23278371 Riboflavin and Ultraviolet Light Reduce the Infectivity of Babesia Microti in Whole Blood Transfusion. Apr, 2013 | Pubmed ID: 22803831 Photochemical Inactivation of Chikungunya Virus in Plasma and Platelets Using the Mirasol Pathogen Reduction Technology System Transfusion. Feb, 2013 | Pubmed ID: 22626525 In Reply To: "Is the SCID Mouse Model Applicable to Human Acute Lung Injury?" Transfusion. Nov, 2012 | Pubmed ID: 23140431 The Utility of Pathogen Inactivation Technology: a Real-life Example of Leishmania Infantum Inactivation in Platelets from a Donor with an Asymptomatic Infection Blood Transfusion = Trasfusione Del Sangue. Oct, 2012 | Pubmed ID: 22790276 Fresh Whole Blood Use for Hemorrhagic Shock: Preserving Benefit While Avoiding Complications Anesthesia and Analgesia. Oct, 2012 | Pubmed ID: 22763908 Preparation of Cryoprecipitate from Riboflavin and UV Light-treated Plasma Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Apr, 2012 | Pubmed ID: 22342281 Quality of Proteins in Riboflavin and UV Light-treated FFP During 1 Year of Storage at -18°C Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Feb, 2012 | Pubmed ID: 22115607 Evaluating Pathogen Reduction of Trypanosoma Cruzi with Riboflavin and Ultraviolet Light for Whole Blood Transfusion. Feb, 2012 | Pubmed ID: 21827502 Improving Blood Safety and Patient Outcomes with Pathogen Reduction Technology Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Dec, 2011 | Pubmed ID: 22078570 Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie. 2011 | Pubmed ID: 21779202 FDA Workshop on Emerging Infectious Diseases: Evaluating Emerging Infectious Diseases (EIDs) for Transfusion Safety Transfusion. Aug, 2011 | Pubmed ID: 21392016 In Vivo Viability of Stored Red Blood Cells Derived from Riboflavin Plus Ultraviolet Light-treated Whole Blood Transfusion. Jul, 2011 | Pubmed ID: 21275998 Protein Stability of Previously Frozen Plasma, Riboflavin and UV Light-treated, Refrozen and Stored for Up to 2 Years at -30 °C Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Feb, 2011 | Pubmed ID: 21251884 Generation of Neutrophil Priming Activity by Cell-containing Blood Components Treated with Pathogen Reduction Technology and Stored in Platelet Additive Solutions Transfusion. Jun, 2011 | Pubmed ID: 21155831 Impact of Pathogen Reduction Technology and Storage in Platelet Additive Solutions on Platelet Function Transfusion. Apr, 2011 | Pubmed ID: 20977485 Hemostatic Function of Buffy Coat Platelets in Additive Solution Treated with Pathogen Reduction Technology Transfusion. Feb, 2011 | Pubmed ID: 20723169 White Blood Cell Inactivation After Treatment with Riboflavin and Ultraviolet Light Transfusion. Nov, 2010 | Pubmed ID: 20529002 In Vitro Cell Quality of Buffy Coat Platelets in Additive Solution Treated with Pathogen Reduction Technology Transfusion. Oct, 2010 | Pubmed ID: 20456708 Defining "adequate" Pathogen Reduction Performance for Transfused Blood Components Transfusion. Aug, 2010 | Pubmed ID: 20374558 Design and Development of a Method for the Reduction of Infectious Pathogen Load and Inactivation of White Blood Cells in Whole Blood Products Biologicals : Journal of the International Association of Biological Standardization. Jan, 2010 | Pubmed ID: 20093041 Evaluation of the Mirasol Pathogen [corrected] Reduction Technology System Against Babesia Microti in Apheresis Platelets and Plasma Transfusion. May, 2010 | Pubmed ID: 20030791 Lack of Antibody Formation to Platelet Neoantigens After Transfusion of Riboflavin and Ultraviolet Light-treated Platelet Concentrates Transfusion. Dec, 2009 | Pubmed ID: 19694996 Understanding Loss of Donor White Blood Cell Immunogenicity After Pathogen Reduction: Mechanisms of Action in Ultraviolet Illumination and Riboflavin Treatment Transfusion. Dec, 2009 | Pubmed ID: 19682337 A Laboratory Comparison of Pathogen Reduction Technology Treatment and Culture of Platelet Products for Addressing Bacterial Contamination Concerns Transfusion. Jun, 2009 | Pubmed ID: 19320867 Evaluation of Potential Immune Response and in Vivo Survival of Riboflavin-ultraviolet Light-treated Red Blood Cells in Baboons Transfusion. Jan, 2009 | Pubmed ID: 18954398 Reduction of Prion Infectivity in Packed Red Blood Cells Biochemical and Biophysical Research Communications. Dec, 2008 | Pubmed ID: 18851948 Toxicity Testing of a Novel Riboflavin-based Technology for Pathogen Reduction and White Blood Cell Inactivation Transfusion Medicine Reviews. Apr, 2008 | Pubmed ID: 18353253 Treatment with Riboflavin and Ultraviolet Light Prevents Alloimmunization to Platelet Transfusions and Cardiac Transplants Transplantation. Nov, 2007 | Pubmed ID: 17998874 Pathogen Inactivation of Trypanosoma Cruzi in Plasma and Platelet Concentrates Using Riboflavin and Ultraviolet Light Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Oct, 2007 | Pubmed ID: 17950672 Inactivation of Orientia Tsutsugamushi in Red Blood Cells, Plasma, and Platelets with Riboflavin and Light, As Demonstrated in an Animal Model Transfusion. Feb, 2007 | Pubmed ID: 17302769 Mirasol PRT Treatment of Donor White Blood Cells Prevents the Development of Xenogeneic Graft-versus-host Disease in Rag2-/-gamma C-/- Double Knockout Mice Transfusion. Sep, 2006 | Pubmed ID: 16965583 The Mirasol PRT System for Pathogen Reduction of Platelets and Plasma: an Overview of Current Status and Future Trends Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis. Aug, 2006 | Pubmed ID: 16935562 Correlation of in Vitro Platelet Quality Measurements with in Vivo Platelet Viability in Human Subjects Vox Sanguinis. May, 2006 | Pubmed ID: 16635070 Functional Inactivation of White Blood Cells by Mirasol Treatment Transfusion. Apr, 2006 | Pubmed ID: 16584442 Platelet Glycolytic Flux Increases Stimulated by Ultraviolet-induced Stress is Not the Direct Cause of Platelet Morphology and Activation Changes: Possible Implications for the Role of Glucose in Platelet Storage Transfusion. Nov, 2005 | Pubmed ID: 16271100 Efficacy of Apheresis Platelets Treated with Riboflavin and Ultraviolet Light for Pathogen Reduction Transfusion. Aug, 2005 | Pubmed ID: 16078923 Comparison of Computerized Formulae for Determination of Platelet Recovery and Survival Transfusion. Jul, 2005 | Pubmed ID: 15987377 Evaluation of Platelet Mitochondria Integrity After Treatment with Mirasol Pathogen Reduction Technology Transfusion. Jun, 2005 | Pubmed ID: 15934990 An Action Spectrum of the Riboflavin-photosensitized Inactivation of Lambda Phage Photochemistry and Photobiology. Mar-Apr, 2005 | Pubmed ID: 15623353 Separation, Identification and Quantification of Riboflavin and Its Photoproducts in Blood Products Using High-performance Liquid Chromatography with Fluorescence Detection: a Method to Support Pathogen Reduction Technology Photochemistry and Photobiology. Nov-Dec, 2004 | Pubmed ID: 15382964 Riboflavin and UV-light Based Pathogen Reduction: Extent and Consequence of DNA Damage at the Molecular Level Photochemistry and Photobiology. Jul-Aug, 2004 | Pubmed ID: 15339215 Photochemical Inactivation of Selected Viruses and Bacteria in Platelet Concentrates Using Riboflavin and Light Transfusion. Jun, 2004 | Pubmed ID: 15157255 राइबोफ्लेविन साथ प्लेटलेट उत्पाद और पराबैंगनी प्रकाश का उपचार: उच्च अनुमापांक जीवाणु संक्रमण के खिलाफ प्रभावशीलता Shawn D. Keil1, Nick Hovenga1, Denise Gilmour1, Susanne Marschner1, Raymond Goodrich1 1Terumo BCT, Scientific Affairs Inmunología e infección
राइबोफ्लेविन साथ प्लेटलेट उत्पाद और पराबैंगनी प्रकाश का उपचार: उच्च अनुमापांक जीवाणु संक्रमण के खिलाफ प्रभावशीलता Shawn D. Keil1, Nick Hovenga1, Denise Gilmour1, Susanne Marschner1, Raymond Goodrich1 1Terumo BCT, Scientific Affairs Inmunología e infección